Isoallopregnanolone antagonize allopregnanolone-induced effects on saccadic eye velocity and self-reported sedation in humans

Psychoneuroendocrinology

Volumn 52, Issue 1, 2015, Pages 22-31

  Bengtsson, Sara K S ^a   Nyberg, Sigrid ^a   Hedström, Helena ^a   Zingmark, Elisabeth ^a   Jonsson, Björn ^b   Bäckström, Torbjörn ^a   Bixo, Marie ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Allopregnanolone; GABAA receptor; Isoallopregnanolone; Premenstrual dysphoric disorder; Saccadic eye velocity; Sedation

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; SEPRANOLONE; ANESTHETIC AGENT; ELTANOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ANTAGONISM; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; NORMAL HUMAN; SACCADIC EYE MOVEMENT; SACCADIC EYE VELOCITY; SEDATION; SELF REPORT; ANTAGONISTS AND INHIBITORS; BLOOD; CONSCIOUS SEDATION; DRUG EFFECTS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WAKEFULNESS; YOUNG ADULT;

ADULT; ANESTHETICS; CONSCIOUS SEDATION; CROSS-OVER STUDIES; FEMALE; HUMANS; PREGNANOLONE; SACCADES; SELF REPORT; SINGLE-BLIND METHOD; WAKEFULNESS; YOUNG ADULT;

EID: 84922679443     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.10.025     Document Type: Article

References (58)

1. Ahboucha S., Gamrani H., Baker G. GABAergic neurosteroids: the endogenous benzodiazepines of acute liver failure. Neurochem. Int. 2012, 60:707-714.
2. Aluoja A., Shlik J., Vasar V., Kingisepp P.H., Jagomagi K., Vasar E., Bradwejn J. Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers. Psychiatry Res. 1997, 66:59-67.
3. Andreen L., Sundstrom-Poromaa I., Bixo M., Andersson A., Nyberg S., Backstrom T. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 2005, 30:212-224.
4. Backstrom T., Bixo M., Johansson M., Nyberg S., Ossewaarde L., Ragagnin G., Savic I., Stromberg J., Timby E., van Broekhoven F., van Wingen G. Allopregnanolone and mood disorders. Prog. Neurobiol. 2014, 113:88-94.
5. Backstrom T., Wahlstrom G., Wahlstrom K., Zhu D., Wang M.D. Isoallopregnanolone; an antagonist to the anaesthetic effect of allopregnanolone in male rats. Eur. J. Pharmacol. 2005, 512:15-21.
6. Ball D.M., Glue P., Wilson S., Nutt D.J. Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Psychopharmacology 1991, 105:361-436.
7. Becker W. The neurobiology of saccadic eye movements. Metrics. Rev. Oculomot. Res. 1989, 3:13-67.
8. Belelli D., Casula A., Ling A., Lambert J.J. The influence of subunit composition on the interaction of neurosteroids with GABAA receptors. Neuropharmacology 2002, 43:651-661.
9. Belelli D., Lambert J.J. Neurosteroids: endogenous regulators of the GABAA receptor. Nat. Rev. Neurosci. 2005, 6:565-575.
10. Bixo M. Biomarkers for premenstrual dysphoric disorder. GABAA modulating steroid antagonists - a possible treatment for premenstrual dysphoric disorder. 44th Annual ISPNE Conference of International Society of Psychoneuroendocrinology 2014, International Society of Psychoneuroendocrinology, Montreal, Canada.
11. de Visser S.J., van der Post J.P., de Waal P.P., Cornet F., Cohen A.F., van Gerven J.M. Biomarkers for the effects of benzodiazepines in healthy volunteers. Br. J. Clin. Pharmacol. 2003, 55:39-50.
12. FASS Förteckning över humanläkemedel (Catalogue of pharmaceuticals) 2013, Läkemedelsindustriföreningens Service.
13. Felipo V. Hepatic encephalopathy: effects of liver failure on brain function. Nat. Rev. Neurosci. 2013, 14:851-858.
14. Gentles W., Thomas E.L. Commentary. Effect of benzodiazepines upon saccadic eye movements in man. Clin. Pharmacol. Ther. 1971, 12:563-574.
15. Gingnell M., Ahlstedt V., Bannbers E., Wikstrom J., Sundstrom-Poromaa I., Fredrikson M. Social stimulation and corticolimbic reactivity in premenstrual dysphoric disorder: a preliminary study. Biol. Mood Anxiety Disord. 2014, 4:3.
16. Glue P. The pharmacology of saccadic eye movements. J. Psychopharmacol. (Oxf.) 1991, 5:377-387.
17. Glue P., Bailey J., Wilson S., Hudson A., Nutt D.J. Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements. Life Sci. 1992, 50:PL25-PL30.
18. Griffiths A.N., Marshall R.W., Richens A. Saccadic eye-movement analysis as a measure of drug effects on human psychomotor performance. Br. J. Clin. Pharmacol. 1984, 18:S73-S82.
19. Hedstrom H., Bixo M., Nyberg S., Spigset O., Zingmark E., Backstrom T. Studies of pharmacokinetic and pharmacodynamic properties of isoallopregnanolone in healthy women. Psychopharmacology (Berl.) 2009, 203:85-98.
20. Hellstadius A. Psykometrisk utprövning av Anxiety Sensitivity Index (Psychometric Evaluation of Anxiety Sensitivity Index) 2000, Department of Psychology, Stockholm University, Stockholm, Sweden.
21. Hommer D.W., Matsuo V., Wolkowitz O., Chrousos G., Greenblatt D.J., Weingartner H., Paul S.M. Benzodiazepine sensitivity in normal human subjects. Arch. Gen. Psychiatry 1986, 43:542-551.
22. Hosie A.M., Clarke L., da Silva H., Smart T.G. Conserved site for neurosteroid modulation of GABA A receptors. Neuropharmacology 2009, 56:149-154.
23. Hosie A.M., Wilkins M.E., Smart T.G. Neurosteroid binding sites on GABA(A) receptors. Pharmacol. Ther. 2007, 116:7-19.
24. Iacano W.G., Lykken D.T. Two-year retest stability of eye performance and comparison of electro-oculographic and infrared recording techniques: evidence of EEG in the electro-oculogram. Psychophysiology 1981, 18:49-55.
25. Le Melledo J.M., Bradwejn J., Koszycki D., Bichet D. Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide. Arch. Gen. Psychiatry 1995, 52:605-606.
26. Lundgren P., Stromberg J., Backstrom T., Wang M.D. Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3 beta-hydroxy-5 alpha-pregnan-20-one (isoallopregnanolone). Brain Res. 2003, 982:45-53.
27. Marshall R.W., Griffiths A.N., Richens A. A microcomputer system to assess CNS depression from an analysis of the dynamics of saccadic eye-movements. Br. J. Clin. Pharmacol. 1985, 20:P304-P305.
28. Marshall R.W., Richens A. An Ibm-based system for the generation, collection and analysis of saccadic and smooth pursuit eye-movements. Br. J. Clin. Pharmacol. 1989, 28:P752-P753.
29. McCormack H.M., Horne D.J., Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol. Med. 1988, 18:1007-1019.
30. Mellon S.H., Griffin L.D., Compagnone N.A. Biosynthesis and action of neurosteroids. Brain Res. Brain Res. Rev. 2001, 37:3-12.
31. Mercer A.J., Marshall R.W., Richens A. Saccadic eye movements as a method of psychometris assessment. Ambulatory Anaesthesia and Sedation 1990, 88-105. Blackwell, Oxford. I. Klepper, L. Sunders, M. Rosen (Eds.).
32. Nyberg S., Backstrom T., Zingmark E., Purdy R.H., Poromaa I.S. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. Gynecol. Endocrinol.: Offi. J. Int. Soc. Gynecol. Endocrinol. 2007, 23:257-266.
33. Nyberg S., Wahlstrom G., Backstrom T., Poromaaa I.S. Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder. Psychoneuroendocrinology 2004, 29:767-777.
34. Peterson R.A., Reiss S. Anxiety Sensitivity Index Manual 1992, International Diagnostics Systems, Worthington, OH. 2nd ed.
35. Purdy R.H., Moore P.H., Rao P.N., Hagino N., Yamaguchi T., Schmidt P., Rubinow D.R., Morrow A.L., Paul S.M. Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids 1990, 55:290-296.
36. Radu D., Ahlin A., Svanborg P., Lindefors N. Anxiogenic effects of the CCK(B) agonist pentagastrin in humans and dose-dependent increase in plasma C-peptide levels. Psychopharmacology (Berl) 2002, 161:396-403.
37. Reiss S., Peterson R.A., Gursky D.M., McNally R.J. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav. Res. Ther. 1986, 24:1-8.
38. Richens A., Mercer A.J., Jones D.M., Griffiths A., Marshall R.W. Effects of zoldipem on saccadic eye movements and psychomotor performance; a double-blind, placebo controlled study in healthy volunteers. Br. J. Pharmacol. 1993, 36:61-65.
39. Romeo E., Strohle A., Spalletta G., di Michele F., Hermann B., Holsboer F., Pasini A., Rupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry 1998, 155:910-913.
40. Schule C., Romeo E., Uzunov D.P., Eser D., di Michele F., Baghai T.C., Pasini A., Schwarz M., Kempter H., Rupprecht R. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity. Mol. Psychiatry 2006, 11:261-272.
41. Spielberger C.D., Gorusch R.L., Lushene R.E. Manual for the State-Trait Anxiety Inventory 1970, Consulting Psychology Press, Palo Alto, CA.
42. Strohle A., Romeo E., di Michele F., Pasini A., Hermann B., Gajewsky G., Holsboer F., Rupprecht R. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch. Gen. Psychiatry 2003, 60:161-168.
43. Strohle A., Romeo E., di Michele F., Pasini A., Yassouridis A., Holsboer F., Rupprecht R. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am. J. Psychiatry 2002, 159:145-147.
44. Stromberg J., Haage D., Taube M., Backstrom T., Lundgren P. Neurosteroid modulation of allopregnanolone and GABA effect on the GABA-A receptor. Neuroscience 2006, 143:73-81.
45. Sundstrom I., Andersson A., Nyberg S., Ashbrook D., Purdy R.H., Backstrom T. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998, 67:126-138.
46. Sundstrom I., Backstrom T. Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology 1998, 23:73-88.
47. Sundstrom I., Nyberg S., Backstrom T. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacol 1997, 17:370-381.
48. Taylor S.P., Koch W.J., McNally R.J. How does anxiety sensitivity vary across the anxiety disorders?. J. Anxiety Disord. 1992, 6:249-259.
49. Timby E., Balgard M., Nyberg S., Spigset O., Andersson A., Porankiewicz-Asplund J., Purdy R.H., Zhu D., Backstrom T., Poromaa I.S. Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl.) 2006, 186:414-424.
50. Turkmen S., Lundgren P., Birzniece V., Zingmark E., Backstrom T., Johansson I.M. 3beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone. Eur. J. Neurosci. 2004, 20:1604-1612.
51. Turkmen S., Wahlstrom G., Backstrom T., Johansson I.M. Persistence of tolerance to the anaesthetic effect of allopregnanolone in male rats. Eur. J. Pharmacol. 2008, 592:73-80.
52. Vallée M., Rivera J.D., Koob G.F., Purdy R.H., Fitzgerald R.L. Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal. Biochem. 2000, 287:153-166.
53. van Steveninck A.L., Schoemaker H.C., Pieters M.S., Kroon R., Breimer D.D., Cohen A.F. A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers. Clin. Pharmacol. Ther. 1991, 50:172-180.
54. van Wingen G.A., van Broekhoven F., Verkes R.J., Petersson K.M., Backstrom T., Buitelaar J.K., Fernandez G. Progesterone selectively increases amygdala reactivity in women. Mol. Psychiatry 2008, 13:325-333.
55. Wang M., He Y., Eisenman L.N., Fields C., Zeng C.-M., Mathews J., Benz A., Fu T., Zorumski E., Steinbach J.H., Covey D.F., Zorumski C.F., Mennerick S. 3β-Hydroxypregnane steroids are pregnenolone sulfate-like GABAA receptor antagonists. J. Neurosci. 2002, 22:3366-3375.
56. Wang M.D., Wahlstrom G., Gee K.W., Backstrom T. Potency of lipid and protein formulation of 5 alpha-pregnanolone at induction of anaesthesia and the corresponding regional brain distribution. Br. J. Anaesth. 1995, 74:553-557.
57. Wisden W., Laurie D.J., Monyer H., Seeburg P.H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci.: Offi. J. Soc. Neurosci. 1992, 12:1040-1062.
58. Zhu D., Wang M.D., Backstrom T., Wahlstrom G. Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in the male rat. Br. J. Anaesth. 2001, 86:403-412.